Abstract: The present invention discloses a patient-reported assessment tool dedicated for assessment of oxaliplatin-induced peripheral neuropathy (OIPN), comprising a main scale, a subscale and a scoring formula. The assessment contents of the main scale contain symptoms of body organs and are graded based on patient's subjective feelings about the frequency of the neuropathy, corresponding to relative scores. The assessment contents of the subscale contain location, duration and influence of the most severe symptom. The present invention effectively improves the accuracy and sensitivity of CIPN assessment through the targeted application range design and the maximum item weight addition, and improves the clinical reference value of CIPN assessment by elaborating the description of OIPN symptoms and integrating the features of several validated assessment tools, and provides reference for the development of CIPN assessment tools.

Abstract: The present disclosure relates to the technical field of alien invasive species control, in particular to use of 4-nitro-3-(trifluoromethyl)phenol in killing or controlling Pomacea canaliculata, a method for killing or controlling the Pomacea canaliculata, and a molluscicide. The present disclosure provides use of 4-nitro-3-(trifluoromethyl)phenol in killing or controlling Pomacea canaliculata. The 4-nitro-3-(trifluoromethyl)phenol can effectively control the Pomacea canaliculata with a low cost. In the present disclosure, the results of examples show that: the 4-nitro-3-(trifluoromethyl)phenol has an obvious killing effect on the Pomacea canaliculata, showing a control effect comparable to that of niclosamide, a commonly-used molluscicide for killing the Pomacea canaliculata.

Abstract: The present invention concerns the use of compounds and compositions for the treatment or prevention of Flavivirus infections, such as dengue virus infections and Zika virus infections. Aspects of the invention include methods for treating or preventing Flavivirus virus infection, such as dengue virus and Zika virus infection, by administering a compound or composition of the invention, to a subject in need thereof; methods for inhibiting Flavivirus infections, such as dengue virus and Zika virus infections, in a cell in vitro or in vivo; pharmaceutical compositions; packaged dosage formulations; and kits useful for treating or preventing Flavivirus infections, such as dengue virus and Zika virus infections.

Abstract: A compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and disclosed is an application thereof in the preparation of a medication for treating diseases related to a CRBN receptor.

Abstract: In an embodiment, an autonomous driving vehicle (ADV) determines a LIDAR type, from of a plurality of LIDAR types, of a LIDAR unit. Responsive to determining the LIDAR type of the LIDAR unit, the ADV configures an adaptive LIDAR data processing system based on the LIDAR type. The adaptive LIDAR data processing system supports each one of the plurality of LIDAR types. In turn, responsive to configuring the adaptive LIDAR data processing system, the ADV establishes communication between the LIDAR unit and a host system using the adaptive LIDAR data processing system.

Abstract: The present disclosure discloses a shielded insulating shell and an electronic device. The shielded insulating shell includes a shell body provided with a first cavity, with an inner shielding layer near the first cavity and an outer shielding layer far away from the first cavity being formed on the shell body; a first structure formed on the first cavity, and formed by assembling to comprise at least a first shielding layer, a first insulating layer, a first air gap layer, a second insulating layer, and a second shielding layer arranged sequentially from an inner side to an outer side of the first cavity; and an assembling gap formed on the first structure, which cooperates with the first air gap layer to form a creepage path on the first structure that extends from the inner shielding layer to the outer shielding layer.

Abstract: The present invention concerns the use of compounds and compositions for the treatment or prevention of Flavivirus infections, such as dengue virus infections and Zika virus infections. Aspects of the invention include methods for treating or preventing Flavivirus virus infection, such as dengue virus and Zika virus infection, by administering a compound or composition of the invention, to a subject in need thereof; methods for inhibiting Flavivirus infections, such as dengue virus and Zika virus infections, in a cell in vitro or in vivo; pharmaceutical compositions; packaged dosage formulations; and kits useful for treating or preventing Flavivirus infections, such as dengue virus and Zika virus infections.

Abstract: The present invention concerns the use of compounds and compositions for the treatment or prevention of Flavivirus infections, such as dengue virus infections and Zika virus infections. Aspects of the invention include methods for treating or preventing Flavivirus virus infection, such as dengue virus and Zika virus infection, by administering a compound or composition of the invention, to a subject in need thereof; methods for inhibiting Flavivirus infections, such as dengue virus and Zika virus infections, in a cell in vitro or in vivo; pharmaceutical compositions; packaged dosage formulations; and kits useful for treating or preventing Flavivirus infections, such as dengue virus and Zika virus infections.

Abstract: A compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and disclosed is an application thereof in the preparation of a medication for treating diseases related to a CRBN receptor.

Abstract: Generally discussed herein are devices, systems, and methods for on-device detection of a wake word. A device can include a memory including model parameters that define a custom wake word detection model, the wake word detection model including a recurrent neural network transducer (RNNT) and a lookup table (LUT), the LUT indicating a hidden vector to be provided in response to a phoneme of a user-specified wake word, a microphone to capture audio, and processing circuitry to receive the audio from the microphone, determine, using the wake word detection model, whether the audio includes an utterance of the user-specified wake word, and wake up a personal assistant after determining the audio includes the utterance of the user-specified wake word.

Abstract: Certain aspects of the present disclosure provide techniques for detecting and preventing web service usage anomalies. Embodiments include forecasting, based on a model, a number of resource instances for one or more web services for a time period. Embodiments include receiving, after the time period has elapsed, a detected number of resource instances for the one or more web services for the time period. Embodiments include comparing the detected number of resource instances to the forecasted number of resource instances. Embodiments include determining, based on the comparing, a usage anomaly. Embodiments include determining an impact of the usage anomaly. Embodiments include outputting an indication of the usage anomaly and the impact of the usage anomaly.

Abstract: Generally discussed herein are devices, systems, and methods for custom wake word selection assistance. A method can include receiving, at a device, data indicating a custom wake word provided by a user, determining one or more characteristics of the custom wake word, determining that use of the custom wake word will cause more than a threshold rate of false detections based on the characteristics, rejecting the custom wake word as the wake word for accessing a personal assistant in response to determining that use of the custom wake word will cause more than a threshold rate of false detections, and setting the custom wake word as the wake word in response to determining that use of the custom wake word will not cause more than the threshold rate of false detections.

Abstract: The present invention concerns the use of compounds and compositions for the treatment or prevention of Flavivirus infections, such as dengue virus infections and Zika virus infections. Aspects of the invention include methods for treating or preventing Flavivirus virus infection, such as dengue virus and Zika virus infection, by administering a compound or composition of the invention, to a subject in need thereof; methods for inhibiting Flavivirus infections, such as dengue virus and Zika virus infections, in a cell in vitro or in vivo; pharmaceutical compositions; packaged dosage formulations; and kits useful for treating or preventing Flavivirus infections, such as dengue virus and Zika virus infections.

Abstract: Embodiments of this application disclose a method and a system for switching a sound channel of a headset, and a headset terminal, to accurately identify and determine a left-ear wearing status and a right-ear wearing status of a headset terminal, and accurately send a left-channel input audio signal and a right-channel input audio signal. A user does not need to manually switch a left channel and a right channel of the headset terminal. This greatly improves convenience of using the headset terminal.

Abstract: The present disclosure provides a communication chip, which is applied to a terminal device and includes a system control module, a radio frequency signal processing module, a first baseband processing module, and a second baseband processing module, where the system control module is respectively connected to the radio frequency signal processing module, the first baseband processing module and the second baseband processing module; the radio frequency signal processing module is further respectively connected to the first baseband processing module and the second baseband processing module.

Abstract: Disclosed are a ZSM-5 molecular sieve and a preparation method and use thereof. In this disclosure, a silicon source, an aluminum source, sodium hydroxide, a template and water are mixed in a rotating micro liquid membrane reactor, and then subjected to a hydrothermal crystallization to obtain the ZSM-5 molecular sieve.

Abstract: The present invention relates to a pyrimidine-based tricyclic compound and a use thereof, and specifically, relates to a pyrimidine-based tricyclic compound and a use thereof in preparation of a drug for treating a related disease. Specifically, disclosed are a compound represented by formula (II), a stereoisomer thereof, and a pharmaceutically acceptable salt thereof.